MUFG Securities Americas’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$961K Buy
4,447
+386
+10% +$73.8K 0.05% 298
2026
Q1
$745K Buy
4,061
+109
+3% +$20.1K 0.05% 321
2025
Q4
$696K Sell
3,952
-2
-0.1% -$327 0.04% 329
2025
Q3
$554K Buy
3,954
+707
+22% +$95.6K 0.04% 370
2025
Q2
$408K Buy
3,247
+656
+25% +$81.7K 0.03% 382
2025
Q1
$355K Buy
2,591
+440
+20% +$62.9K 0.04% 359
2024
Q4
$329K Buy
+2,151
New +$363K 0.04% 347

Other funds holding BIIB

MUFG Securities Americas's BIIB Position: Q2 2026 in Review

MUFG Securities Americas increased its Biogen (BIIB) stake by 9.5% in Q2 2026, buying an estimated $73.8K and bringing the position to 4,447 shares worth $961K. The position accounts for 0.05% of the portfolio, ranked #298.

MUFG Securities Americas first reported a position in BIIB in Q4 2024 and has held it in 7 quarters since. 1,045 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • MUFG Securities Americas held 4,447 shares of Biogen worth $961K as of Q2 2026.
  • MUFG Securities Americas bought 386 Biogen shares in Q2 2026, an estimated $73.8K.
  • Biogen made up 0.05% of MUFG Securities Americas's portfolio in Q2 2026, its #298 holding.
  • MUFG Securities Americas first reported a position in Biogen in Q4 2024 and has held it in 7 quarters since.
  • 1,045 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on MUFG Securities Americas's 13F filing for Q2 2026, filed 14 Aug 2026.